Print（PDF/79KB） Sep. 17, 2020 Corporate

Sumitomo Dainippon Pharma Announces Change in Executive Officer

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following change in Executive Officer, effective October 1, 2020:

Change in Executive Officer

Change in the position assumed by Executive Officer (effective October 1, 2020)

Position as of October 1, 2020	Current position	Name
Executive Officer Executive Research Director, Drug Research Division Senior Director, Research Planning & Coordination	Executive Officer Executive Research Director, Drug Research Division	Hideyuki Harada